Spire Healthcare Group PLC (SPI) PT Raised to GBX 350 at Jefferies Group LLC

Spire Healthcare Group PLC (LON:SPI) had its price objective raised by Jefferies Group LLC from GBX 305 ($3.94) to GBX 350 ($4.52) in a report released on Thursday. Jefferies Group LLC currently has a hold rating on the stock.

SPI has been the subject of several other research reports. Liberum Capital restated a buy rating and set a GBX 400 ($5.17) price target on shares of Spire Healthcare Group PLC in a research report on Thursday, March 2nd. Berenberg Bank reiterated a buy rating and set a GBX 360 ($4.65) target price on shares of Spire Healthcare Group PLC in a research report on Tuesday, March 14th. JPMorgan Chase & Co. reiterated a neutral rating and set a GBX 433 ($5.60) target price on shares of Spire Healthcare Group PLC in a research report on Friday, March 3rd. Numis Securities Ltd reiterated an add rating and set a GBX 360 ($4.65) target price on shares of Spire Healthcare Group PLC in a research report on Thursday, March 2nd. Finally, Morgan Stanley reiterated an equal weight rating and set a GBX 350 ($4.52) target price on shares of Spire Healthcare Group PLC in a research report on Monday, March 20th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of Hold and a consensus price target of GBX 361 ($4.66).

Shares of Spire Healthcare Group PLC (LON SPI) opened at 334.90 on Thursday. The company’s 50 day moving average is GBX 339.04 and its 200-day moving average is GBX 334.67. Spire Healthcare Group PLC has a one year low of GBX 295.00 and a one year high of GBX 411.00. The firm’s market capitalization is GBX 1.34 billion.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Mideast Time and is owned by of Mideast Time. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.mideasttime.com/spire-healthcare-group-plc-spi-pt-raised-to-gbx-350-at-jefferies-group-llc/1757996.html.

In other news, insider Simon Gordon sold 58,539 shares of the firm’s stock in a transaction that occurred on Thursday, March 30th. The shares were sold at an average price of GBX 328 ($4.24), for a total value of £192,007.92 ($248,104.30).

About Spire Healthcare Group PLC

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:SPI”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.